Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Carbamazepine
- Therapeutic area
- CNS & mental health
- Drug class
- Antiepileptics
- ATC
- N03
- Strength
- 400 mg
- Dosage form
- Tablet
- Pack
- 50's
- Registration no.
- 119666
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 564.88 to 592.79 (+4.9%) between 1 Jul 2025 and 20 Aug 2026 · 2 official price records · pack 50's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Carbamazapine Carbamazapine 400 mg, 50's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/carbamazapine-carbamazapine-400-mg-119666-50s-biogen-pharma/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 592.79 | 2026-08-20 | 2026-09-22 | DRAP PharmaPrice Index (refreshed from snapshot #84) | Current |
| PKR 564.88 | 2025-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 119666Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
